KA Imaging Reports: Study Demonstrates Reveal 35C’s Impact in the ICU: Enhanced Imaging, Faster Diagnosis, and Potential CT Diversion

Better image quality, same reading times or faster, increased confidence in diagnosis, reduced time to potential intervention, and potential to divert cases from CT imaging. This is a summary of a study using the Reveal 35C detector in the ICU, to be presented at this year’s American Society of Emergency Radiology Meeting reports KA Imaging.

Quoting directly from the study: “In certain cases, especially when computed tomography (CT) is not an option, dual-energy X-ray can permit improved visualization of soft tissues by subtracting unwanted structural noise […] and simultaneously reducing unnecessary radiation exposure. Medical lines and tubes can be better visualized using the bone image that dual-energy X-ray detectors also produce.”

Radiologist Vikram Venkatesh, one of the study’s authors, explained the difficulties of imaging in the ICU: “In addition to their critical condition requiring intensive care, ICU patients often have multiple lines, tubes, and implantable devices, making it challenging to transport them to the medical imaging department.”

The study at Grand River Hospital (GRH), a 665-bed community hospital, focused on how the Reveal 35C detector could address these challenges by providing dual-energy images directly at the bedside. Seventeen respondents were interviewed, including radiologists and intensivists.

Results were positive for more than half of the physicians in all areas, with reported better image quality, no added or faster reading times, increased confidence in diagnosis, and a reduction in time to potential intervention.

Another outcome observed was the potential for CT diversion. In addition to the self-reported reduction trend noted by intensivists, data collected at the hospital showed a decrease in the number of chest CTs during the study period compared to other time frames: a 37.5% decrease compared to the prior 3 months and a 16.67% decline compared to the identical period in the previous year.

In the ICU, due to the capitated nature of reimbursement, hospitals are encouraged to manage costs effectively. “Along with the cost savings from each avoided CT scan, there are further benefits like avoiding re-intubation, reducing transport risks, and improving infection control,” analyzed Amol Karnick, president and CEO of KA Imaging.

The American Society of Emergency Radiology (ASER) Meeting will be held from September 11 to 14 in Washington, DC. In addition to the poster session, visitors can learn about KA Imaging’s technology at the technical exhibition.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.